The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Share:
More In Business
The Business of Snack Nostalgia, A Favorite Returns!
Dan Fachner, CEO of J&J Snack Foods, shares how Dippin’ Dots is returning to stores and how the company is innovating for summer snack demand.
From Gas Pumps to Grocery Aisles: Inflation’s Grip Tightens
Elizabeth Renter, Senior Economist at NerdWallet, breaks down how inflation and oil price shocks are driving higher costs and squeezing consumers today.
Delivery Gets Personal: Inside the Next Wave of AI Robots
Ali Kashani, CEO of Serve Robotics, explains how Maggie is redefining delivery with AI, edge computing, and human-like interaction on city streets.
From SpaceX to Hollywood: The Deals Reshaping 2026
Dena Jalbert, founder and CEO of Align Business Advisory Services, breaks down 2026’s M&A surge, SpaceX IPO buzz, and major media shakeups.
Chocolate Hangover: Why Prices Are Staying High After Valentine’s Day & Easter
David Branch of Wells Fargo explains why cocoa prices are falling but some candy costs remain high and when consumers may finally see relief at checkout.
Understanding Artemis II: Humanity’s Next Giant Leap Toward the Moon
Colonel Chris Hadfield, astronaut and best-selling author, breaks down Artemis II and why NASA’s next crewed mission is key to returning humans to the Moon.
Why This War Could Change Oil Forever
Ben Geman, Energy Reporter at Axios, explains how the Iran war could reshape global energy—disrupting supply, shifting power, and accelerating a new regime.
War, Trade, and Rates: What’s Moving Markets Now
Max Gokhman, Deputy Chief Investment Officer of Franklin Templeton, breaks down how geopolitics is shaping markets and what it means for investors.
America’s Offices Sit Empty Despite RTO Mandates
Emily Peck, National Correspondent at Axios, explains why office vacancies hit 21% despite RTO pushes, highlighting a lasting shift in how Americans work.
